The Promise of Asexual Malaria Vaccine Development

View More View Less
  • Affymax Research Institute, Santa Clara, California
Restricted access

This review presents several reasons to support the belief that an asexual vaccine for human malaria caused by Plasmodium falciparum will be developed. It lists many of the current vaccine candidates that we think are ready for human trials and it summarizes a strategy for the development of an asexual vaccine.